FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Drug-Eluting Peripheral Transluminal Angioplasty Catheter

PMA: P190019 · Supplement: S002 · Decision Nov 12, 2020
Classifications
1
FEI Numbers
26
Registration Numbers
26

Basic Information

Device Name
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
Trade Name
Ranger Paclitaxel-Coated PTA Balloon Catheter
PMA Number
P190019
Supplement Number
S002
Device Class
FDA Class 3
Product Code
ONU
Generic Name
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
November 12, 2020
Date Received
November 9, 2020
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Replacement of the current software with new software to collect and process manufacturing test data.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
ONU Drug-Eluting Peripheral Transluminal Angioplasty Catheter